Identity matrix

Mblue Labs Discovers Anti-Aging Power In Methylene Blue, Launches Bluelene Face&Neck Remodel Mask

Retrieved on: 
星期三, 三月 13, 2024
Scientific Reports, Health, Skin care, ECM, Face, Retinol, Radical (chemistry), Cell nucleus, Peptide, Extracellular matrix, DNA, Research, ROS, Mitochondrion, Methylene blue, Skin, Collagen, DNA repair, UMD, Identity matrix, Human, Ageing, Neck, Cosmetics

Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.

Key Points: 
  • Bethesda, Maryland--(Newsfile Corp. - March 13, 2024) - Mblue Labs proudly announces the debut of the Face & Neck Remodel Mask, a groundbreaking addition to their renowned skincare brand, Bluelene.
  • Mblue Labs, a woman and minority-owned business, is dedicated to advancing skincare science, and this latest product embodies their commitment to unparalleled innovation.
  • Methylene Blue penetrates skin cells at the mitochondrial level, creating cell health and proliferation.
  • To view an enhanced version of this graphic, please visit:
    The Face & Neck Remodel Mask features a powerful blend of the latest age-reversal ingredients, including Methylene Blue, Growth Factors, Advanced Peptides, and Niacinamide.

Wealth 362: The Revenue Institute Launches Wealth 362 to Scale Asset Management Firms

Retrieved on: 
星期五, 一月 19, 2024
Identity matrix, Revenue, Advertising, SMB, Book, SMS, Marketing, Automation, Growth

Novi, Michigan--(Newsfile Corp. - January 19, 2024) - The Revenue Institute just launched Wealth 362 to help wealth management firms grow faster.

Key Points: 
  • Novi, Michigan--(Newsfile Corp. - January 19, 2024) - The Revenue Institute just launched Wealth 362 to help wealth management firms grow faster.
  • Wealth 362 was based on a model that has worked for regional asset management firms to the Fortune 500.
  • Wealth 362 is based around two technologies that the Revenue Institute has built to help any company compete on a global scale.
  • With Wealth 362, the average asset management firm is now able to bring on qualified financial advisors with existing books of business easier than ever.

NEEDED ANNOUNCES NEW BREAKTHROUGH SUPPLEMENT, SPERM SUPPORT+

Retrieved on: 
星期三, 七月 19, 2023
Male, DNA, Pregnancy, Lycopene, OBGYN, Research, Coenzyme Q10, Acetylcysteine, Semen, Vitamin, Fertility, Oxidative stress, Men's health, Testosterone, LOS, Health, Probiotic, Environment, God Needs Men, Identity matrix, Antioxidant, Dietary supplement, Birth control

LOS ANGELES, July 19, 2023 /PRNewswire/ -- Needed, the breakthrough nutritional supplement brand creating new standards for perinatal wellness, today announced the launch of Sperm Support+. This product will help men maximize their role in successful, healthy conception. Male fertility factors in 40-50% of fertility struggles, warranting a needed conversation around the shared role of both partners in pregnancy outcomes. Sperm Support+ addresses male fertility with an expertly formulated, whole-body approach using targeted antioxidants, probiotics, and testosterone-supporting botanicals to boost sperm quality, quantity, and motility.

Key Points: 
  • With Studies Showing Male Sperm Counts Down 50+% Over the Last 50 Years,
    LOS ANGELES, July 19, 2023 /PRNewswire/ -- Needed, the breakthrough nutritional supplement brand creating new standards for perinatal wellness, today announced the launch of Sperm Support+ .
  • Sperm Support+ addresses male fertility with an expertly formulated, whole-body approach using targeted antioxidants, probiotics, and testosterone-supporting botanicals to boost sperm quality, quantity, and motility.
  • Needed Sperm Support+ is a whole-body approach to supporting men's fertility, combining clinically-studied ingredients to address multiple factors, including sperm health, hormone levels, and microbiome balance.
  • Sperm Support+ is available starting at $40 and as part of the comprehensive Needed Men's Fertility Support Plan.

The Estée Lauder Companies Shares New Preclinical and Clinical Findings at World Congress of Dermatology Spanning Emerging Research Areas that Support Skin Health and Longevity

Retrieved on: 
星期四, 七月 6, 2023
Histology, La mer, Senior, Skin care, Xeroderma, SIRT2, 3D, Elastin, Clinical trial, Enzyme, EL, Ageing, Glycation, SIRT, AGE, Woman, Hyaluronic acid, Research, Sirtuin, Science, Thought, DE, Clinique, Congress, Parity, Beauty, Erythema, UV, ELC, Randomized controlled trial, Irritation, Hyperpigmentation, BrainScope Company, Inc., Advanced glycation end-product, Ozone, Knowledge, Poster, R, Longevity, Autostereogram, Human, NYSE, Identity matrix, Skin, N-Acetylglucosamine, Cosmetics, Medical imaging, Dietary supplement, Medical device, Dermatology

NEW YORK, July 6, 2023 /PRNewswire/ -- The Estée Lauder Companies Inc. (ELC) (NYSE: EL) today announced that the company and several of its brands presented a range of novel preclinical and clinical findings at the 25th World Congress of Dermatology, held this week in Singapore. The poster and satellite symposium presentations reflect a strong portfolio of prestige beauty and skin care brands effectively translating biological learnings and progressive research efforts into meaningful innovation, including better methods to care for and protect skin.

Key Points: 
  • With rapidly emerging knowledge and advancements from the dermatologic and scientific communities, the science of skin care has never been more important," said Lisa Napolione, Senior Vice President, Global Research & Development (R&D).
  • "As we live longer, research on health span and longevity will only accelerate.
  • To meet these innovation challenges, we are thinking differently, and in a manner enabled by novel science across all our global laboratories and clinics."
  • Using 3D skin models, researchers studied the anti-glycation properties of 6 compounds to determine their capacities to reduce auto-fluorescence in 3D skin models.